Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Contribution of imaging to the diagnosis of optic neuropathies.
DMDs Are an Essential Issue But Are They the Only Issue in MS Treatment?
The gut microbiota and its correlations with the central nervous system disorders.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
New data at AAN to confirm efficacy of Novartis' Gilenya® across four key measures of MS disease activity, including brain volume loss
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis.
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
[Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal.]
Translating Fatigue to Human Performance.
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.
Added benefit of fampridine is not proven
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
B cells and antibodies in multiple sclerosis pathogenesis and therapy.
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
The Diagnostic Accuracy of Static Posturography in Predicting Accidental Falls in People With Multiple Sclerosis.
A randomized trial of stress management for the prevention of new brain lesions in MS.
Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk Stratification.
The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
The prospects of minocycline in multiple sclerosis.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.

Pages